Last updated on April 18, 2014 at 1:21 EDT

ShangPharma to Attend Two Upcoming Investor Conferences

November 28, 2011

SHANGHAI, Nov. 28, 2011 /PRNewswire-Asia/ — ShangPharma Corporation (NYSE: SHP) (“ShangPharma” or the “Company”), a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced that it is scheduled to present at the following investor conferences in December 2011:

Ms. Lan Xie, Vice President of Finance and Investor Relations of ShangPharma, will present at the following conferences:

  • Deutsche Bank 5th Annual MedTools Investor Summit, December 5-6, 2011, Boston
  • Oppenheimer 22nd Annual Healthcare Conference, December 13-14, 2011, New York City

Presentation materials will be available under the Webcasts & Presentations section of the Company’s investor relations website at http://ir.shangpharma.com.


ShangPharma Corporation (NYSE: SHP) is a leading China-based contract research organization providing high quality and cost-effective services for the pharmaceutical and biotechnology industry. It offers a broad range of high-quality, integrated services across the drug discovery and development process to help international and Chinese pharmaceutical and biotechnology companies discover and develop novel drug candidates efficiently. ShangPharma’s services consist of discovery chemistry, discovery biology and preclinical development, pharmaceutical development and biologics services. For more information, please visit www.shangpharma.com.

    For further information, please contact:
    Ms. Lan Xie
    VP of Finance and Investor Relations
    Email: ir@shangpharma.com

    Brunswick Group
    Lilian Wong
    Email: shangpharma@brunswickgroup.com
    Phone: 86-10-5960-8600

SOURCE ShangPharma Corporation

Source: PR Newswire